General Registry on Cancer in the Poitou-Charentes Region (Certified 2013-2015 Registry) FRESH-PEF200-en Pierre INGRAND General Registry on Cancer in the Poitou-Charentes Region (Certified 2013-2015 Registry) FRESH-PEF200-en 200 FRESH-PEF200 Pierre INGRAND UNIVERSITE DE POITIERS Epidemiology France Portal (PEF) INSTITUT NATIONAL DU CANCER (INCA) null Pierre;INGRAND region registry public health Oncology Register aims in terms of public healthcare (monitoring, assessment): The aim of the register is to provide benchmarks for describing the dynamics of cancer progression (distribution, progression and impact of the disease according to the geography and demographics of the population) and to become involved in the evaluation of screening and prevention (by assessing the effectiveness of the programmes in place) and care assessment (analysing treatment paths used by patients; factors that determine diagnostic care management and distribution of good practice recommendations). It shall play a specialist role in aiding the assessment of public policies by the Regional Health Agency (ARS), in collaboration with other regional organisations (Poitou-Charentes Cancer Network, Regional Health Observatory and screening facilities). It shall participate in producing national (FRANCIM) and international (IARC) statistics. Register aims in terms of research: Two research areas are preferred for continuing research conducted by the Public Health Team in Poitiers. 1) Assessing factors that affect access to screening facilities (access to screening facilities for sibship-based index cases) and assessing factors affecting access to care (patient satisfaction; access to technical surgical platforms and waiting periods for radiotherapy). 2) Automated classification of textual information contained in electronic anatomic pathology and cytopathology reports (collaboration with University of Rennes 1). null France Nouvelle-Aquitaine Individuals Patients population Male Female Infant, Newborn (birth to 28 days) Infant (28 days to 2 years) Child, Preschool (2 to 5 years) Child (6 to 12 years) Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) All cases of malignant invasive tumours (haematologic malignancies and solid tumours excluding basal cell carcinoma of the skin); in situ tumours; borderline ovarian tumours; as well as benign tumours or tumours with unpredictable progression in the brain and bladder. Advanced colorectal adenomas will be passively recorded. Clinical data Socio-demographic data Health event/morbidity Other [1000-10000[ individuals Converting or copying information into a structured record Observational Study Observational Study Morbidity registry 3,323 invasive cancers/217 in situ carcinomas Unknown Restricted access Contact the principal investigator Access on specific project only